The risk of parkinson disease associated with urate in a community-based cohort of older adults

Neuroepidemiology

Volumn 36, Issue 4, 2011, Pages 223-229

  Jain, S ^a,c   Ton, T G ^d   Boudreau, R M ^b   Yang, M ^b   Thacker, E L ^d   Studenski, S ^a   Longstreth Jr , W T ^d   Strotmeyer, E S ^b   Newman, A B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Pittsburgh School of Medicine ^*  (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Epidemiology; Oxidative stress; Parkinson disease; Risk factors; Uric acid

Indexed keywords

URATE;

AGED; ARTICLE; COMMUNITY SAMPLE; FEMALE; GERIATRIC PATIENT; HUMAN; INCIDENTAL FINDING; LOCALLY WEIGHTED SCATTERPLOT SMOOTHING REGRESSION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; REGRESSION ANALYSIS; RISK ASSESSMENT; URIC ACID BLOOD LEVEL;

AGED; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MARYLAND; NORTH CAROLINA; PARKINSON DISEASE; PENNSYLVANIA; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; URIC ACID;

EID: 79958766891     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000327748     Document Type: Article

References (24)

1. Schlesinger I, Schlesinger N: Uric acid in Parkinson's disease. Mov Disord 20 08; 23: 1653-1657.
2. de Lau LM, Koudstaal PJ, Hofman A, Bre-teler MM: Serum uric acid levels and the risk of Parkinson disease. Annals Neurol 2005; 58: 797-800. (Pubitemid 41552559)
3. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM: Observations on serum uric acid levels and the risk of id-iopathic Parkinson's disease. Am J Epidemiol 1996; 144:480-484. (Pubitemid 26296131)
4. Weisskopf MG, O'Reilly E, Chen H, Schwarz-schild MA, Ascherio A: Plasma urate and risk of Parkinson's disease. Am J Epidemiol 2007; 16 6: 561-567. (Pubitemid 47283643)
5. Annanmaki T, Muuronen A, Murros K: Low plasma uric acid level in Parkinson's disease. Mov Disord 2007; 22:1133-1137. (Pubitemid 47067223)
6. Chen HM, Mosley TH, Alonso A, Huang X: Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) Study. American J Epidemiol 2009; 169:1064-1069.
7. Lippi G, Montagnana M, Franchini M, Fa-valoro EJ, Targher G: The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008; 392: 1-7.
8. Strazzullo P, Puig JG: Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007; 17: 409-414.
9. Fried LP, Borhani NO, Enright P, et al: The Cardiovascular Health Study: design and ra-tiona le. Ann Epidemiol 1991; 1: 263-276.
10. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993; 3: 358-366. (Pubitemid 23195820)
11. Ton TG, Jain S, Boudreau B, Thacker EL, Strotmeyer ES, Newman AB, Longstreth WT, Checkoway H: Post hoc Parkinson's: Identifying an uncommon disease in the Cardiovascular Health Study. Neuroepide-miolog y 2010; 35: 241-249.
12. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Healt h Study. Clin Chem 1995; 41: 264-270.
13. Chonchol M, Shlipak MG, Katz R, et al: Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50: 239-247. (Pubitemid 47095076)
14. Shlipak MG, Fried LF, Cushman M, et al: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293:1737-1745.
15. Kumar A, Prineas RJ, Arnold AM, et al: Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study. Circulation 2008; 11 8: 2790-2796.
16. O'Reilly EJ, Gao X, Weisskopf MG, et al: Plasma urate and Parkinson's disease in women. Am J Epidemiol 2010; 172:666-670.
17. Nilsen J, Brinton RD: Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004; 3:297-313. (Pubitemid 39242916)
18. Tell GS, Rutan GH, Kronmal RA, et al: Correlates of blood pressure in community-dwelling older adults: the Cardiovascular Health Study. Cardiovascular Health Study (CHS) Collaborative Research Group. Hypertension 1994; 23: 59-67. (Pubitemid 24022045)
19. Ekundayo OJ, Dell'Italia LJ, Sanders PW, et al: Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol 2010; 14 2: 279-287.
20. Edwards NL: The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol 2009; 21:132-137.
21. Beach TG, Adler CH, Sue LI, et al: Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119:689-702.
22. Orimo S, Uchi hara T, Na k amura A, et al: A x-onal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic ner ve in Parkinson's disease. Bra in 2008; 131: 642-650. (Pubitemid 351294710)
23. Miyake Y, Tanaka K, Fukushima W, et al: Case-control study of risk of Parkinson's disease in relation to hypertension, hypercho-lesterolemia, and diabetes in Japan. J Neurol Sci 2010; 293: 82-86.
24. Shah A, Keenan RT: Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? Curr Rheumatol Rep 2010; 12: 118-124.